Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue
Xuemei Zhang,1–3 Xuejuan Li,1,4 Hongchen Hua,1 Aiping Wang,1 Wanhui Liu,1–3 Youxin Li,1–3 Fenghua Fu,1–3 Yanan Shi,5 Kaoxiang Sun1 1School of Pharmacy, Yantai University, Yantai, Shandong Province, People’s Republic of China; 2State Key Laboratory o...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2017-08-01
|
| Series: | International Journal of Nanomedicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/cyclic-hexapeptide-conjugated-nanoparticles-enhance-curcumin-delivery--peer-reviewed-article-IJN |
| _version_ | 1818682231840833536 |
|---|---|
| author | Zhang X Li X Hua H Wang A Liu W Li Y Fu F Shi Y Sun K |
| author_facet | Zhang X Li X Hua H Wang A Liu W Li Y Fu F Shi Y Sun K |
| author_sort | Zhang X |
| collection | DOAJ |
| description | Xuemei Zhang,1–3 Xuejuan Li,1,4 Hongchen Hua,1 Aiping Wang,1 Wanhui Liu,1–3 Youxin Li,1–3 Fenghua Fu,1–3 Yanan Shi,5 Kaoxiang Sun1 1School of Pharmacy, Yantai University, Yantai, Shandong Province, People’s Republic of China; 2State Key Laboratory of Long-acting and Targeting Drug Delivery System, Yantai, Shandong Province, People’s Republic of China; 3Luye Pharmaceutical Co., Ltd., Shandong Province, People’s Republic of China; 4National Engineering and Technology Research Center of Chirality Pharmaceutical, Lunan Pharmaceutical Group Co., Ltd., Shandong Province, People’s Republic of China; 5School of Pharmacy, Binzhou Medical University, Shandong Province, People’s Republic of China Abstract: Glioma has one of the highest mortality rates among primary brain tumors. The clinical treatment for glioma is very difficult due to its infiltration and specific growth locations. To achieve improved drug delivery to a brain tumor, we report the preparation and in vitro and in vivo evaluation of curcumin nanoparticles (Cur-NPs). The cyclic hexapeptide c(RGDf(N-me)VK)-C (cHP) has increased affinity for cells that overexpress integrins and was designed to target Cur-NPs to tumors. Functional polyethyleneglycol-modified poly(D,L-lactide-co-glycolide) (PEG-PLGA) conjugated to cHP was synthesized, and targeted Cur-NPs were prepared using a self-assembly nanoprecipitation process. The physicochemical properties and the in vitro cytotoxicity, accuracy, and penetration capabilities of Cur-NPs targeting cells with high levels of integrin expression were investigated. The in vivo targeting and penetration capabilities of the NPs were also evaluated against glioma in rats using in vivo imaging equipment. The results showed that the in vitro cytotoxicity of the targeted cHP-modified curcumin nanoparticles (cHP/Cur-NPs) was higher than that of either free curcumin or non-targeted Cur-NPs due to the superior ability of the cHP/Cur-NPs to target tumor cells. The targeted cHP/Cur-NPs, c(RGDf(N-me)VK)-C-modified Cur-NPs, exhibited improved binding, uptake, and penetration abilities than non-targeting NPs for glioma cells, cell spheres, and glioma tissue. In conclusion, c(RGDf(N-me)VK)-C can serve as an effective targeting ligand, and cHP/Cur-NPs can be exploited as a potential drug delivery system for targeting gliomas. Keywords: glioma targeting, integrin targeting, c(RGDf(N-me)VK)-C peptide, curcumin nanoparticles, in vitro and in vivo evaluation |
| first_indexed | 2024-12-17T10:15:34Z |
| format | Article |
| id | doaj.art-0376f592f98744b28208773229cd976d |
| institution | Directory Open Access Journal |
| issn | 1178-2013 |
| language | English |
| last_indexed | 2024-12-17T10:15:34Z |
| publishDate | 2017-08-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | International Journal of Nanomedicine |
| spelling | doaj.art-0376f592f98744b28208773229cd976d2022-12-21T21:52:55ZengDove Medical PressInternational Journal of Nanomedicine1178-20132017-08-01Volume 125717573234155Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissueZhang XLi XHua HWang ALiu WLi YFu FShi YSun KXuemei Zhang,1–3 Xuejuan Li,1,4 Hongchen Hua,1 Aiping Wang,1 Wanhui Liu,1–3 Youxin Li,1–3 Fenghua Fu,1–3 Yanan Shi,5 Kaoxiang Sun1 1School of Pharmacy, Yantai University, Yantai, Shandong Province, People’s Republic of China; 2State Key Laboratory of Long-acting and Targeting Drug Delivery System, Yantai, Shandong Province, People’s Republic of China; 3Luye Pharmaceutical Co., Ltd., Shandong Province, People’s Republic of China; 4National Engineering and Technology Research Center of Chirality Pharmaceutical, Lunan Pharmaceutical Group Co., Ltd., Shandong Province, People’s Republic of China; 5School of Pharmacy, Binzhou Medical University, Shandong Province, People’s Republic of China Abstract: Glioma has one of the highest mortality rates among primary brain tumors. The clinical treatment for glioma is very difficult due to its infiltration and specific growth locations. To achieve improved drug delivery to a brain tumor, we report the preparation and in vitro and in vivo evaluation of curcumin nanoparticles (Cur-NPs). The cyclic hexapeptide c(RGDf(N-me)VK)-C (cHP) has increased affinity for cells that overexpress integrins and was designed to target Cur-NPs to tumors. Functional polyethyleneglycol-modified poly(D,L-lactide-co-glycolide) (PEG-PLGA) conjugated to cHP was synthesized, and targeted Cur-NPs were prepared using a self-assembly nanoprecipitation process. The physicochemical properties and the in vitro cytotoxicity, accuracy, and penetration capabilities of Cur-NPs targeting cells with high levels of integrin expression were investigated. The in vivo targeting and penetration capabilities of the NPs were also evaluated against glioma in rats using in vivo imaging equipment. The results showed that the in vitro cytotoxicity of the targeted cHP-modified curcumin nanoparticles (cHP/Cur-NPs) was higher than that of either free curcumin or non-targeted Cur-NPs due to the superior ability of the cHP/Cur-NPs to target tumor cells. The targeted cHP/Cur-NPs, c(RGDf(N-me)VK)-C-modified Cur-NPs, exhibited improved binding, uptake, and penetration abilities than non-targeting NPs for glioma cells, cell spheres, and glioma tissue. In conclusion, c(RGDf(N-me)VK)-C can serve as an effective targeting ligand, and cHP/Cur-NPs can be exploited as a potential drug delivery system for targeting gliomas. Keywords: glioma targeting, integrin targeting, c(RGDf(N-me)VK)-C peptide, curcumin nanoparticles, in vitro and in vivo evaluationhttps://www.dovepress.com/cyclic-hexapeptide-conjugated-nanoparticles-enhance-curcumin-delivery--peer-reviewed-article-IJNglioma targetingintegrin targetingc(RGDf(N-me)VK)-C peptidecurcumin nanoparticles |
| spellingShingle | Zhang X Li X Hua H Wang A Liu W Li Y Fu F Shi Y Sun K Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue International Journal of Nanomedicine glioma targeting integrin targeting c(RGDf(N-me)VK)-C peptide curcumin nanoparticles |
| title | Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue |
| title_full | Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue |
| title_fullStr | Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue |
| title_full_unstemmed | Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue |
| title_short | Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue |
| title_sort | cyclic hexapeptide conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue |
| topic | glioma targeting integrin targeting c(RGDf(N-me)VK)-C peptide curcumin nanoparticles |
| url | https://www.dovepress.com/cyclic-hexapeptide-conjugated-nanoparticles-enhance-curcumin-delivery--peer-reviewed-article-IJN |
| work_keys_str_mv | AT zhangx cyclichexapeptideconjugatednanoparticlesenhancecurcumindeliverytogliomatumorcellsandtissue AT lix cyclichexapeptideconjugatednanoparticlesenhancecurcumindeliverytogliomatumorcellsandtissue AT huah cyclichexapeptideconjugatednanoparticlesenhancecurcumindeliverytogliomatumorcellsandtissue AT wanga cyclichexapeptideconjugatednanoparticlesenhancecurcumindeliverytogliomatumorcellsandtissue AT liuw cyclichexapeptideconjugatednanoparticlesenhancecurcumindeliverytogliomatumorcellsandtissue AT liy cyclichexapeptideconjugatednanoparticlesenhancecurcumindeliverytogliomatumorcellsandtissue AT fuf cyclichexapeptideconjugatednanoparticlesenhancecurcumindeliverytogliomatumorcellsandtissue AT shiy cyclichexapeptideconjugatednanoparticlesenhancecurcumindeliverytogliomatumorcellsandtissue AT sunk cyclichexapeptideconjugatednanoparticlesenhancecurcumindeliverytogliomatumorcellsandtissue |